关键信息
-
基因名
PNLIP/Pancreatic lipase
- 应用
-
别名
PNLIP; PTL; Pancreatic Lipase; Pancreatic triacylglycerol lipase
-
种属
Rat
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
P27657
-
表达区间
Ser47~His280
-
分子量
32kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
Pancreatic lipase (PNLIP) is a crucial enzyme in human digestion, primarily responsible for the hydrolysis of dietary triglycerides into free fatty acids and monoglycerides. Its functional significance extends beyond digestion, as it plays a vital role in nutrient absorption and metabolic processes. Research on recombinant PNLIP has gained momentum due to its potential applications in various fields, including medicine, nutrition, and biotechnology. The production of recombinant PNLIP using techniques like recombinant DNA technology allows for the generation of large quantities of the enzyme, which can be used for in vitro studies and therapeutic applications. Understanding the structure-function relationship of PNLIP through recombinant methods can provide insights into its enzymatic mechanism and regulatory pathways, enhancing our ability to manipulate its activity for improved digestive health. Moreover, recombinant PNLIP can serve as a model for studying lipase family enzymes, facilitating advancements in enzyme engineering and drug design. Given the increasing prevalence of obesity and metabolic disorders linked to lipid metabolism, optimizing the activity of PNLIP through recombinant approaches holds promise for developing novel interventions aimed at enhancing lipid digestion and absorption in affected individuals. Overall, the study of recombinant pancreatic lipase is advancing our knowledge of lipid metabolism and may pave the way for therapeutic innovations in gastrointestinal health.
